RA Capital Management - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 138 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$83,797,841
-30.9%
3,984,681
-19.1%
1.70%
-34.3%
Q3 2022$121,301,000
+1.7%
4,922,9410.0%2.59%
-18.6%
Q2 2022$119,283,000
-6.0%
4,922,9410.0%3.18%
+14.9%
Q1 2022$126,864,000
-27.2%
4,922,941
-12.3%
2.77%
-9.9%
Q4 2021$174,272,000
+28.0%
5,614,4280.0%3.07%
+62.9%
Q3 2021$136,150,000
+66.2%
5,614,4280.0%1.89%
+43.5%
Q2 2021$81,915,000
-41.6%
5,614,4280.0%1.32%
-37.8%
Q1 2021$140,192,000
+12.9%
5,614,428
+23.2%
2.11%
+21.7%
Q4 2020$124,225,0004,557,8671.74%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 895,821$8,008,6403.99%
Deep Track Capital, LP 7,370,000$65,887,8002.54%
VR Adviser, LLC 2,623,677$23,455,6722.47%
Sio Capital Management, LLC 884,770$7,909,8442.45%
Kynam Capital Management, LP 957,502$8,560,0681.40%
MPM BioImpact LLC 552,846$4,942,4431.32%
ARMISTICE CAPITAL, LLC 7,500,000$67,050,0001.03%
Parkman Healthcare Partners LLC 577,494$5,162,7960.95%
Tri Locum Partners LP 251,702$2,250,2160.72%
Cheyne Capital Management (UK) LLP 26,200$234,2280.68%
View complete list of TRAVERE THERAPEUTICS INC shareholders